Načítá se...
DPP-4 Inhibitors Improve Liver Dysfunction in Type 2 Diabetes Mellitus
BACKGROUND: Dipeptidyl peptidase-4 (DPP-4) inhibitors might have pleiotropic effects because receptors for incretin exist in various tissues, including liver. We examined whether DPP-4 inhibitors affect liver function in patients with type 2 diabetes. MATERIAL/METHODS: A retrospective review of 459...
Uloženo v:
| Hlavní autoři: | , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
International Scientific Literature, Inc.
2014
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4173801/ https://ncbi.nlm.nih.gov/pubmed/25228119 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.12659/MSM.890989 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|